“Alliance has been successful because of our persistence, focus, resource-rich ability to adapt to different environments, and our strong leadership team.  We are always spearheading new initiatives and taking our investments to the next level,” said Reinberg.

The company is excited by the market changes and invests in in the healthcare industry because of its resilience to downturns.  In this economy, many see commercial real estate as a buying opportunity, especially when done properly.  According to Reinberg, healthcare is also among the fastest growing industries, with respect to demand.  Both service demand and worker demand play key roles in the success of this industry, especially in the South, Southeast, Southwest, Mountain, and the Western regions of the United States.

“Our ‘sweet spot’ is medical and veterinary properties with a population of at least 50,000 permanent residents within a 5-mile radius,” notes Reinberg.  “Rent growth in the initial lease term, investment in properties by the tenants, and whether they are private or public organizations” all play key roles in the Alliance decision-making process. “Each of our criteria are designed to maximize the value and return for each side deal,” added Reinberg.

Alliance certainly isn’t the only company investing in the health and veterinary commercial real estate spaces, but they have tackled many of the misconceptions about the space head on.    Those include everything from risk to returns.  The Alliance team understands this and clearly realizes the importance of everything from education to selecting the right partners when it comes to investing.  For Ben Reinberg and his highly skilled Alliance team, this is literally what they handle every day.

“The biggest misconception I hear is that investing in medical office assets is too risky.  It’s ironic because the human body is never going out of style.  It’s our foundation, as well as that of our tenants’ businesses.  Another misconception is that investing in medical office assets provides low returns.  Alliance has average mid 20s IRR in our medical investment space.  We consistently provide low-risk investments with opportunistic returns.” 

While the company is selective about their investments, they are also keenly focused on their growth as well.  They recently launched a new fun to raise additional capital for more commercial transactions and plan to do a lot of purchasing over the next 18-24 months.  

For those that have already invested in the commercial real estate space, or those that are simply looking for consistent returns in an ever-changing economy, Alliance offers a variety of investment opportunities.

The post How To Win In Commercial Property Investment appeared first on Baltimore News Journal.

The study will be conducted in two phases and will begin with a precision-like focus on the identification and screening of trial candidates.  Once milestones are achieved and regulatory controls are in place, the second phase will begin. In Phase Two, subjects will be enrolled in the study and the study will begin in full force.

“At Stanford, we are pleased to collaborate on this grant from NIH,” said Judith Prochaska, PhD, MPH, Professor of Medicine with the Stanford Prevention Research Center. “It will support a randomized controlled trial evaluation of Ria Health’s telehealth intervention to increase screening and treatment for alcohol use disorder.”

There are many reasons this study has the potential to change the trajectory of AUD treatment.  For example, since 2012, U.S. life expectancy has been significantly reduced.  Alcohol use has been a consistent contributor to this reduction in life expectancy. In 2020, for example, 28.3 million people suffered from AUD in the U.S. alone.  That is a staggering number.   As the number continues to grow, treatment rates have been consistently declining.  The only way to stop this cycle is with consistent and innovative treatment and care.

“This grant is a step towards preventative evidence-based interventions that can help reduce the alarming increases rates of cirrhosis that are disproportionately affecting people under the age of 45 and women who are misusing alcohol,” said Tom Nix, CEO of Ria Health. “Early detection of liver abnormalities and treatments for alcohol misuse are proven to reduce acute liver disease which require life altering treatments and cause high mortality rates.”

For those in treatment, the Ria Health Program focuses on a reduction in alcohol consumption.  This is achieved through a medical attention, counseling, and more. Several FDA-approved medications for AUD are also used that, when used in addition to effective counseling, have been proven effective in long-term treatment. Participants also use a Bluetooth device to track and monitor blood alcohol levels, as part of the program. Unlike other AUD programs, the Ria program doesn’t mandate complete and total abstinence from alcohol.  This focus, instead, is on tangible behavior modifications.

More information about the grant can be found online at:

https://reporter.nih.gov/search/0rkfTR_5QUiK4A2JP9NSFA/project-details/10604054 and riahealth.com.   

About Ria Health

Over their lifetime, 1 in 10 adults will struggle with alcohol use disorder, the third-leading cause of preventable death in the United States. At Ria Health, we envision a world with accessible, effective, and compassionate treatment for people who suffer from alcohol misuse. Ria Health is the first evidence-based telehealth treatment program for people who want to drink less and live better by changing their relationship with alcohol. We combine medical science, technology, and human compassion to help people rapidly improve their lives with a simple, online alcohol treatment program that works. For more information, visit www.riahealth.com.

The post The National Institutes Of Health Awards RIA Health Major Grant appeared first on Baltimore News Journal.